Literature DB >> 16265186

Is there a role for apheresis in gastrointestinal disorders?

Toshifumi Hibi1, Atsushi Sakuraba.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16265186     DOI： 10.1038/ncpgasthep0168

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  5 in total

1.  A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.

Authors:  Atsushi Sakuraba; Toshiro Sato; Makoto Naganuma; Yuichi Morohoshi; Katsuyoshi Matsuoka; Nagamu Inoue; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

2.  The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis.

Authors:  Mingming Zhu; Xitao Xu; Fang Nie; Jinlu Tong; Shudong Xiao; Zhihua Ran
Journal:  Int J Colorectal Dis       Date:  2011-04-08       Impact factor: 2.571

3.  Leukocytapheresis for the treatment of active pouchitis: a pilot study.

Authors:  Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

4.  Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis.

Authors:  Hiroshi Yamasaki; Keiichi Mitsuyama; Junya Masuda; Nobuo Tomiyasu; Hiroko Takedatsu; Hirotada Akashi; Satoshi Matsumoto; Hidetoshi Takedatsu; Kotaro Kuwaki; Osamu Tsuruta; Michio Sata
Journal:  Dig Dis Sci       Date:  2009-03-04       Impact factor: 3.199

5.  A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.

Authors:  Taku Kobayashi; Katsuyoshi Matsuoka; Yoko Yokoyama; Takashi Nakamura; Tomoko Ino; Toyoko Numata; Hiroshi Shibata; Hirofumi Aoki; Yoshihiro Matsuno; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2017-06-08       Impact factor: 7.527
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.